SpinTech receives FDA 510(k) clearance for Stage imaging software
SpinTech received FDA 510(k) clearance for its MRI software Stage, according to a press release.
Stage enables full brain scanning within 5 minutes and shows 16 types of image contrasts, six of which include critical quantitative data. This helps with diagnostic accuracy, which in turn, according to the release, improves treatment for patients.
“Stage’s novel acquisition technique and post-processing software, which grew from the world’s top MRI research groups, is designed to enhance visualization of biomarkers that couldn’t be seen in the brain before while improving throughput and accuracy, making it a significant advancement in imaging,” Ward Detweiler, president and CEO of SpinTech, said in the release. “The FDA clearance allows us to utilize Stage to help patients in real clinical environments.”